Skip to main content

News

Press Release
12/20/2022
KYOTO, Japan, Dec. 16, 2022 /-- OMRON Healthcare Co., Ltd. will exhibit at Consumer Electronics Show (CES) 2023, the world's largest consumer tech show taking place in Las Vegas from Thursday, January 5,...
KYOTO, Japan, Dec. 16, 2022 /-- OMRON Healthcare Co., Ltd. will exhibit at Consumer Electronics Show (CES) 2023, the world's largest consumer tech show taking place in Las Vegas from Thursday, January 5,...
KYOTO, Japan, Dec. 16,...
12/20/2022
EP Lab Digest
Press Release
12/16/2022
REHOVOT, Israel, Dec. 15, 2022 /-- CardiaCare, a clinical stage digital therapeutic company developing the world's first non-invasive, personalized neuromodulation wearable for atrial fibrillation treatment, announced...
REHOVOT, Israel, Dec. 15, 2022 /-- CardiaCare, a clinical stage digital therapeutic company developing the world's first non-invasive, personalized neuromodulation wearable for atrial fibrillation treatment, announced...
REHOVOT, Israel, Dec....
12/16/2022
EP Lab Digest
Press Release
12/16/2022
Collaboration to Add Comprehensive Arrhythmia Monitoring Services Under CareXM's TouchPointCare Telemedicine Platform
Collaboration to Add Comprehensive Arrhythmia Monitoring Services Under CareXM's TouchPointCare Telemedicine Platform
Collaboration to Add...
12/16/2022
EP Lab Digest
Press Release
12/14/2022
• Innovative approach can deliver high-fidelity cardiopulmonary exercise test results comparable to gold-standard testing with a wearable sensor during routine daily activities • Eliminates need for in-clinic testing and exhaustive physical...
• Innovative approach can deliver high-fidelity cardiopulmonary exercise test results comparable to gold-standard testing with a wearable sensor during routine daily activities • Eliminates need for in-clinic testing and exhaustive physical...
• Innovative approach can...
12/14/2022
EP Lab Digest
Press Release
12/14/2022
LAKE OSWEGO, Ore., Dec. 12, 2022 /-- BIOTRONIK, a global leader in the treatment of cardiac and vascular disease is pleased to announce the first patient enrollment in BIO-CONDUCT, an FDA-approved investigational device exemption...
LAKE OSWEGO, Ore., Dec. 12, 2022 /-- BIOTRONIK, a global leader in the treatment of cardiac and vascular disease is pleased to announce the first patient enrollment in BIO-CONDUCT, an FDA-approved investigational device exemption...
LAKE OSWEGO, Ore., Dec. 12,...
12/14/2022
EP Lab Digest
Press Release
12/14/2022
CARDIFF-BY-THE-SEA, Calif. and BOULDER, Colo., Dec. 13, 2022 /--Today, Field Medical, Inc. and CardioNXT, Inc. announce a strategic collaboration to provide the first-of-its-kind, purpose built, focal pulsed field ablation...
CARDIFF-BY-THE-SEA, Calif. and BOULDER, Colo., Dec. 13, 2022 /--Today, Field Medical, Inc. and CardioNXT, Inc. announce a strategic collaboration to provide the first-of-its-kind, purpose built, focal pulsed field ablation...
CARDIFF-BY-THE-SEA,...
12/14/2022
EP Lab Digest
Press Release
12/14/2022
Acquisition expands the Maxwell Biomedical product and intellectual property portfolio.
Acquisition expands the Maxwell Biomedical product and intellectual property portfolio.
Acquisition expands the Maxwell...
12/14/2022
EP Lab Digest
Press Release
12/13/2022
The peer-reviewed publication shows 81% lower heart failure hospitalizations per year and a 48% decrease in rehospitalizations from the national average at 30 days.
The peer-reviewed publication shows 81% lower heart failure hospitalizations per year and a 48% decrease in rehospitalizations from the national average at 30 days.
The peer-reviewed publication...
12/13/2022
EP Lab Digest
Press Release
12/09/2022
Clinical trial will enroll more than 3,000 patients across 75 participating hospitals in U.S.
Clinical trial will enroll more than 3,000 patients across 75 participating hospitals in U.S.
Clinical trial will enroll more...
12/09/2022
EP Lab Digest
Press Release
12/09/2022
Recognizes Exemplary Board Practices Related to DE&I December 08, 2022 10:30 AM Eastern Standard Time--MASON, Ohio--AtriCure Inc., a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial...
Recognizes Exemplary Board Practices Related to DE&I December 08, 2022 10:30 AM Eastern Standard Time--MASON, Ohio--AtriCure Inc., a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial...
Recognizes Exemplary Board...
12/09/2022
EP Lab Digest